Aspo (ASPO) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
22 Oct, 2026Financial performance review
Approved the 2025 financial statements and consolidated financial statements; discharged the Board and CEO from liability for FY 2025.
Board and executive committee updates
Confirmed seven Board members and re-elected Patricia Allam, Annika Ekman, Tapio Kolunsarka, Mikael Laine, Kaarina Ståhlberg, Tatu Vehmas and Heikki Westerlund.
Heikki Westerlund was elected Chair and Mikael Laine Vice Chair; committee chairs and members were appointed for the Human Resources and Remuneration Committee and Audit Committee.
Monthly Board fees and committee meeting fees remained unchanged: €6,000 for the Chair, €4,400 for the Vice Chair, €3,000 for other Board members, and €800/€1,200 for committee members/chairs per meeting.
Dividend announcements
Approved a dividend of EUR 0.25 per share for FY 2025, payable in one instalment; record date April 21, 2026, and payment date April 28, 2026.
Latest events from Aspo
- Profitability surged in H1 2026, with a demerger and Leipurin divestment driving growth.ASPO
Q2 2026 - Stable EBITA and strong cash flow driven by Leipurin divestment and strategic transformation.ASPO
Q1 2026 - EBITA up 25% to EUR 36.5m; transformation and higher 2026 EBITA guided.ASPO
Q4 2025 - Profitability improved in Q3 2025, driven by divestments, investments, and efficiency gains.ASPO
Q3 2025 - Profitability and net sales rose, driven by acquisitions and vessel investments, despite market headwinds.ASPO
Q2 2025 - Q3 2024 net sales up 13%, EBITA EUR 8.7m, driven by acquisitions and green investments.ASPO
Q3 2024 - Q2 2024 saw 16% sales growth, improved profitability, and major strategic acquisitions.ASPO
Q2 2024 - Q1 2025 saw robust sales and profit growth, driven by acquisitions and efficiency gains.ASPO
Q1 2025 - Sales and EBITA grew in 2024, with heavy green investments and a positive 2025 outlook.ASPO
Q4 2024